লোডিং...
No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
BACKGROUND: The use of hydroxychloroquine (HCQ), with or without concurrent administration of azithromycin (AZM), for treatment of COVID-19 has received considerable attention. The purpose of this study was to determine whether HCQ administration is associated with improved mortality in COVID-19 pat...
সংরক্ষণ করুন:
| প্রকাশিত: | Int J Infect Dis |
|---|---|
| প্রধান লেখক: | , , , , , , , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7834474/ https://ncbi.nlm.nih.gov/pubmed/33359949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.12.060 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|